| 2020 - Present | Liquid Diagnostics LLC | Consulting Scientist | |
| 2017 - 2020 | EZLife Bio Inc | R&D Director | |
| 2015 - 2017 | UCLA Dentistry | T90 Postdoctoral Scholar | |
| 2012-2015 | UCLA Dentistry | T32 Predoctoral Scholar | |
| 2011 | Evidia Biosciences | Consultant | |
| 2009 - 2012 | UCLA Engineering | Teacher’s Assistant | |
| 2008 | Genefluidics | Intern |
UCLA Biomedical Engineering
UCLA Biomedical Engineering
UCLA Bioengineering
- M. K. Tu, et al. “The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population,” J.I., p. ji2100919, Jan. 2022, doi: 10.4049/jimmunol.2100919.
- S. H. Chiang, M.Tu, et al., “Development and validation of a quantitative, non-invasive, highly sensitive and specific, electrochemical assay for anti-SARS-CoV-2 IgG antibodies in saliva,” PLoS ONE, vol. 16, no. 7, p. e0251342, Jul. 2021, doi: 10.1371/journal.pone.0251342.
- M. Tu et al., “Rapid PCR-Free Meat Species Identification using Electric Field Induced Release and Measurement (EFIRM®),” Analytica Chimica Acta, p. S000326701931414X, Nov. 2019, doi: 10.1016/j.aca.2019.11.051.
- M. Tu et al., “Electric Field Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva,” The Journal of Molecular Diagnostics, p. S1525157820303500, Jun. 2020, doi: 10.1016/j.jmoldx.2020.05.005.
- M. Tu, D. Chia, F. Wei, and D. Wong, “Liquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB),” The Analyst, 2016, doi: 10.1039/C5AN01863C.
- M. Suh et al., “A Remote Patient Monitoring System for Congestive Heart Failure,” Journal of Medical Systems, vol. 35, no. 5, pp. 1165–1179, May 2011, doi: 10.1007/s10916-011-9733-y.